Targeting the gram-negative bacteria peptidoglycan synthase MraY as a new approach for monoclonal antibody anti-bacterial activity
The use of antibiotics to target bacteria is a well-validated approach for controlling infections in animals and humans. Peptidoglycan biosynthesis is a crucial process in bacteria, and the conserved peptidoglycan synthase MraY is an attractive target for drug design. However, due to the lack of det...
Saved in:
Main Authors: | Jun Cao (Author), Fei Yi (Author), Qiufeng Tian (Author), Guanghui Dang (Author), Wei Si (Author), Siguo Liu (Author), Shenye Yu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New MraY<sub>AA</sub> Inhibitors with an Aminoribosyl Uridine Structure and an Oxadiazole
by: Hongwei Wan, et al.
Published: (2022) -
The MraY Inhibitor Muraymycin D2 and Its Derivatives Induce Enlarged Cells in Obligate Intracellular <i>Chlamydia</i> and <i>Wolbachia</i> and Break the Persistence Phenotype in <i>Chlamydia</i>
by: Iris Löckener, et al.
Published: (2024) -
Clearance of Gram-Negative Bacterial Pathogens from the Ocular Surface by Predatory Bacteria
by: Eric G. Romanowski, et al.
Published: (2021) -
Gram-Negative Bacterial Lysins
by: Chandrabali Ghose, et al.
Published: (2020) -
Anti-bacterial performance of azithromycin nanoparticles as colloidal drug delivery system against different gram-negative and gram-positive bacteria
by: Morteza Azhdarzadeh, et al.
Published: (2012)